ahsct for highly active and rapidly evolving severe ms during the covid-19 pandemic
Published 4 years ago • 528 plays • Length 42:22Download video MP4
Download video MP3
Similar videos
-
57:37
prof gavin giovannoni: managing ms remotely during the covid-19 pandemic
-
55:48
webinar: the impact of covid-19 on multiple sclerosis management
-
1:00:22
anti-cd20 therapies and covid-19 | ms academy
-
1:06:28
update of covid-19 and ms – morbidity and mortality figures | ms academy
-
58:32
how to prepare in the event of you getting covid-19 | ms academy #mscovid19
-
59:07
ask an ms expert – impact of covid-19 on those living with multiple sclerosis
-
24:53
dr sharmilee gnanapavan: the use of biomarkers and csf analysis in patients with ms during covid-19
-
1:35:39
multiple sclerosis in the covid-19 era: what you need to know | a webinar for patients
-
58:42
debate on the nhs england algorithm for ms treatment by disease-modifying drugs
-
1:44
guidelines for ahsct in ms
-
1:29:14
ask the experts: #mscovid19 q&a for msers with prof jeremy hobart & dr david paling
-
50:23
pregnancy – what should we advise our patients during the covid-19 pandemic? | ms academy
-
34:00
professor basil sharrack and professor john snowden - ahsct and the management of ms
-
1:14:47
formalising remote management of multiple sclerosis | ms academy #mscovid19
-
26:38
the implications of having multiple sclerosis during covid-19
-
14:23
dr david paling: what i learnt from ms academy webinars
-
58:22
should ocrelizumab & cladribine be treated in the same way as alemtuzumab in terms of covid-19 risk?
-
28:14
ask an ms expert: covid-19 pandemic to endemic
-
1:33:53
ms education: multiple sclerosis and covid-19 | ohio state medical center